학술논문

168P Sacituzumab govitecan (SG) efficacy in patients with metastatic triple-negative breast cancer (mTNBC) by HER2 immunohistochemistry (IHC) status: Findings from the phase III ASCENT study
Document Type
Abstract
Source
In Annals of Oncology May 2022 33 Supplement 3:S200-S201
Subject
Language
ISSN
0923-7534